AQR Capital Management
IMNM icon

AQR Capital Management’s Immunome IMNM Stock Holding History

AQR Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Buy
+18,728
New +$417K ﹤0.01% 3235
2025
Q1 		– Sell
-10,276
Closed -$109K – 3170
2024
Q4 		$109K Sell
10,276
-11,703
-53% -$141K ﹤0.01% 2757
2024
Q3 		$321K Buy
21,979
+5,915
+37% +$84K ﹤0.01% 2365
2024
Q2 		$194K Buy
16,064
+4,129
+35% +$64.6K ﹤0.01% 2427
2024
Q1 		$295K Buy
+11,935
New +$242K ﹤0.01% 2134

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

AQR Capital Management's IMNM Position: Q1 2026 in Review

AQR Capital Management opened a new position in Immunome (IMNM) in Q1 2026: 18,728 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #3235 among its holdings. This is a return to the name: AQR Capital Management previously reported a position in IMNM as recently as Q4 2024.

AQR Capital Management first reported a position in IMNM in Q1 2024 and has held it in 5 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • AQR Capital Management held 18,728 shares of Immunome worth $410K as of Q1 2026.
  • Immunome was a new AQR Capital Management position in Q1 2026.
  • Immunome made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3235 holding.
  • AQR Capital Management first reported a position in Immunome in Q1 2024 and has held it in 5 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.